Skip to content

Injecting Plasma-rich Platelets & Hyaluronic Acid for Patients With Stress Urinary Incontinence

A Pilot Study of Injecting Plasma-rich Platelets and Hyaluronic Acid for Patients With Stress INCONTINENCE; A NON-RANDOMIZED CLINICAL TRIAL

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06012370
Enrollment
20
Registered
2023-08-25
Start date
2023-09-01
Completion date
2023-10-31
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Incontinence, Female

Brief summary

Injection of PRP and hyaluronic acid in stress incontinence patients

Detailed description

Operative details Dissection of the ant vag wall from the urethra and lower part of the bladder Identify the bladder neck using Foly s catheter injection of 1.5 to 2 ml PRP combined with Hyaluronic acid suburethra almost at the level of mid urethra (avoiding the bl neck) then closure of the vag wall ( after removal of the excess vag tissue.

Interventions

PROCEDUREPRP injection

Injection of PRP and hyaluronic acid

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* stress incontinence patients

Exclusion criteria

* prolapse patients

Design outcomes

Primary

MeasureTime frameDescription
Stress incontinence change6 monthsVisual Assessment System assessment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026